Enfusion Historical Balance Sheet

ENFN Stock

USD 11.00 0.15 1.35%

Trend analysis of Enfusion balance sheet accounts such as Other Current Liabilities of 13.8 M or Total Current Liabilities of 14.2 M provides information on Enfusion's total assets, liabilities, and equity, which is the actual value of Enfusion to its prevalent stockholders. By breaking down trends over time using Enfusion balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Enfusion latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Enfusion is a good buy for the upcoming year.

Enfusion Inventory

7.37 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.

About Enfusion Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Enfusion at a specified time, usually calculated after every quarter, six months, or one year. Enfusion Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Enfusion and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Enfusion currently owns. An asset can also be divided into two categories, current and non-current.

Enfusion Balance Sheet Chart

At this time, Enfusion's Other Stockholder Equity is very stable compared to the past year. As of the 17th of February 2025, Net Invested Capital is likely to grow to about 64.8 M, while Total Assets are likely to drop about 88.2 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Enfusion assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Enfusion books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Enfusion balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Enfusion are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Enfusion's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Enfusion current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.At this time, Enfusion's Other Stockholder Equity is very stable compared to the past year. As of the 17th of February 2025, Net Invested Capital is likely to grow to about 64.8 M, while Total Assets are likely to drop about 88.2 M.

	2023	2024	2025 (projected)
Short and Long Term Debt Total	15.4M	13.9M	13.2M
Total Assets	109.0M	125.3M	88.2M

Short Long Term Debt Total Total Assets

Enfusion balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital
Total Assets		-0.44	0.86	0.85	0.9	-0.53	0.91	0.85	-0.97	-0.79	-0.86	0.96	0.94	0.86	0.88	0.28	0.9	0.94	0.96	-0.1	-0.84	0.84	0.9	0.95	-0.82	0.95
Short Long Term Debt Total	-0.44		-0.21	-0.27	-0.76	-0.3	-0.75	-0.38	0.55	0.84	0.57	-0.49	-0.45	-0.39	-0.42	-0.14	-0.03	-0.45	-0.39	0.16	0.84	-0.42	-0.43	-0.65	0.86	-0.65
Other Current Liab	0.86	-0.21		0.89	0.76	-0.79	0.78	0.98	-0.88	-0.49	-0.85	0.82	0.72	0.98	0.97	-0.14	0.84	0.72	0.91	0.23	-0.66	0.93	0.69	0.84	-0.63	0.83
Total Current Liabilities	0.85	-0.27	0.89		0.72	-0.52	0.74	0.89	-0.79	-0.48	-0.9	0.77	0.63	0.89	0.88	-0.11	0.79	0.63	0.96	0.42	-0.64	0.92	0.54	0.77	-0.61	0.77
Total Stockholder Equity	0.9	-0.76	0.76	0.72		-0.32	1.0	0.83	-0.96	-0.93	-0.88	0.91	0.87	0.84	0.87	0.18	0.65	0.87	0.86	-0.13	-0.99	0.82	0.84	0.99	-0.98	0.99
Other Liab	-0.53	-0.3	-0.79	-0.52	-0.32		-0.34	-0.68	0.54	0.05	0.41	-0.46	-0.48	-0.68	-0.67	0.13	-0.69	-0.48	-0.53	-0.11	0.19	-0.6	-0.47	-0.45	0.16	-0.44
Net Tangible Assets	0.91	-0.75	0.78	0.74	1.0	-0.34		0.85	-0.96	-0.91	-0.89	0.91	0.86	0.86	0.88	0.15	0.65	0.86	0.86	-0.1	-0.99	0.84	0.83	0.99	-0.98	0.99
Property Plant And Equipment Net	0.85	-0.38	0.98	0.89	0.83	-0.68	0.85		-0.89	-0.57	-0.91	0.82	0.7	1.0	1.0	-0.2	0.74	0.7	0.91	0.28	-0.76	0.97	0.65	0.88	-0.73	0.87
Current Deferred Revenue	-0.97	0.55	-0.88	-0.79	-0.96	0.54	-0.96	-0.89		0.84	0.88	-0.96	-0.93	-0.9	-0.93	-0.19	-0.82	-0.93	-0.92	0.12	0.91	-0.86	-0.9	-0.99	0.89	-0.99
Net Debt	-0.79	0.84	-0.49	-0.48	-0.93	0.05	-0.91	-0.57	0.84		0.7	-0.81	-0.85	-0.58	-0.63	-0.45	-0.5	-0.85	-0.67	0.41	0.95	-0.58	-0.83	-0.88	0.96	-0.89
Retained Earnings	-0.86	0.57	-0.85	-0.9	-0.88	0.41	-0.89	-0.91	0.88	0.7		-0.77	-0.72	-0.91	-0.91	-0.01	-0.64	-0.72	-0.91	-0.18	0.84	-0.97	-0.61	-0.89	0.82	-0.89
Accounts Payable	0.96	-0.49	0.82	0.77	0.91	-0.46	0.91	0.82	-0.96	-0.81	-0.77		0.91	0.83	0.86	0.16	0.86	0.91	0.92	-0.08	-0.86	0.75	0.92	0.94	-0.85	0.94
Cash	0.94	-0.45	0.72	0.63	0.87	-0.48	0.86	0.7	-0.93	-0.85	-0.72	0.91		0.71	0.75	0.51	0.84	1.0	0.82	-0.41	-0.82	0.68	0.98	0.91	-0.81	0.92
Non Current Assets Total	0.86	-0.39	0.98	0.89	0.84	-0.68	0.86	1.0	-0.9	-0.58	-0.91	0.83	0.71		1.0	-0.19	0.74	0.71	0.91	0.27	-0.77	0.97	0.66	0.89	-0.74	0.88
Non Currrent Assets Other	0.88	-0.42	0.97	0.88	0.87	-0.67	0.88	1.0	-0.93	-0.63	-0.91	0.86	0.75	1.0		-0.15	0.76	0.75	0.92	0.21	-0.8	0.95	0.71	0.92	-0.77	0.91
Other Assets	0.28	-0.14	-0.14	-0.11	0.18	0.13	0.15	-0.2	-0.19	-0.45	-0.01	0.16	0.51	-0.19	-0.15		0.25	0.51	0.07	-0.84	-0.19	-0.1	0.46	0.17	-0.2	0.2
Long Term Debt	0.9	-0.03	0.84	0.79	0.65	-0.69	0.65	0.74	-0.82	-0.5	-0.64	0.86	0.84	0.74	0.76	0.25		0.84	0.88	-0.06	-0.54	0.69	0.83	0.74	-0.51	0.75
Cash And Short Term Investments	0.94	-0.45	0.72	0.63	0.87	-0.48	0.86	0.7	-0.93	-0.85	-0.72	0.91	1.0	0.71	0.75	0.51	0.84		0.82	-0.41	-0.82	0.68	0.98	0.91	-0.81	0.92
Net Receivables	0.96	-0.39	0.91	0.96	0.86	-0.53	0.86	0.91	-0.92	-0.67	-0.91	0.92	0.82	0.91	0.92	0.07	0.88	0.82		0.17	-0.79	0.91	0.76	0.9	-0.76	0.9
Common Stock Shares Outstanding	-0.1	0.16	0.23	0.42	-0.13	-0.11	-0.1	0.28	0.12	0.41	-0.18	-0.08	-0.41	0.27	0.21	-0.84	-0.06	-0.41	0.17		0.15	0.27	-0.45	-0.11	0.18	-0.13
Non Current Liabilities Total	-0.84	0.84	-0.66	-0.64	-0.99	0.19	-0.99	-0.76	0.91	0.95	0.84	-0.86	-0.82	-0.77	-0.8	-0.19	-0.54	-0.82	-0.79	0.15		-0.75	-0.79	-0.95	1.0	-0.95
Inventory	0.84	-0.42	0.93	0.92	0.82	-0.6	0.84	0.97	-0.86	-0.58	-0.97	0.75	0.68	0.97	0.95	-0.1	0.69	0.68	0.91	0.27	-0.75		0.58	0.86	-0.72	0.85
Other Current Assets	0.9	-0.43	0.69	0.54	0.84	-0.47	0.83	0.65	-0.9	-0.83	-0.61	0.92	0.98	0.66	0.71	0.46	0.83	0.98	0.76	-0.45	-0.79	0.58		0.87	-0.79	0.88
Other Stockholder Equity	0.95	-0.65	0.84	0.77	0.99	-0.45	0.99	0.88	-0.99	-0.88	-0.89	0.94	0.91	0.89	0.92	0.17	0.74	0.91	0.9	-0.11	-0.95	0.86	0.87		-0.94	1.0
Total Liab	-0.82	0.86	-0.63	-0.61	-0.98	0.16	-0.98	-0.73	0.89	0.96	0.82	-0.85	-0.81	-0.74	-0.77	-0.2	-0.51	-0.81	-0.76	0.18	1.0	-0.72	-0.79	-0.94		-0.94
Net Invested Capital	0.95	-0.65	0.83	0.77	0.99	-0.44	0.99	0.87	-0.99	-0.89	-0.89	0.94	0.92	0.88	0.91	0.2	0.75	0.92	0.9	-0.13	-0.95	0.85	0.88	1.0	-0.94

Click cells to compare fundamentals

Enfusion Account Relationship Matchups

Enfusion balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	39.1M	106.1M	123.8M	109.0M	125.3M	88.2M
Other Current Liab	5.6M	4.4M	7.4M	11.4M	13.2M	13.8M
Total Current Liabilities	10.7M	8.1M	17.4M	20.3M	23.4M	14.2M
Total Stockholder Equity	(233.6M)	55.3M	65.0M	53.7M	61.7M	64.8M
Property Plant And Equipment Net	8.8M	13.1M	22.5M	32.6M	37.5M	39.4M
Net Debt	84.6M	(64.4M)	(55.6M)	(20.2M)	(18.2M)	(17.2M)
Retained Earnings	67.8M	(328K)	(178.9M)	(172.9M)	(155.6M)	(147.9M)
Accounts Payable	484K	2.5M	1.7M	2.2M	2.5M	1.6M
Cash	13.9M	64.4M	62.5M	35.6M	40.9M	40.1M
Non Current Assets Total	10.2M	16.4M	27.0M	39.1M	45.0M	47.2M
Non Currrent Assets Other	1.4M	3.4M	4.5M	6.5M	7.5M	7.9M
Other Assets	1.4M	3.4M	4.5M	1.0	1.15	1.09
Cash And Short Term Investments	13.9M	64.4M	62.5M	35.6M	40.9M	40.1M
Net Receivables	12.2M	18.2M	25.9M	28.1M	32.3M	20.5M
Liabilities And Stockholders Equity	39.1M	106.1M	123.8M	109.0M	125.3M	88.2M
Non Current Liabilities Total	262.0M	538K	3.0M	11.2M	10.1M	9.6M
Other Current Assets	2.8M	13.1M	8.4M	6.2M	7.1M	7.0M
Other Stockholder Equity	(233.3M)	226.7M	244.3M	226.9M	260.9M	274.0M
Total Liab	272.7M	8.6M	20.3M	31.5M	28.3M	26.9M
Net Invested Capital	(135.0M)	55.3M	65.0M	53.7M	61.7M	64.8M
Property Plant And Equipment Gross	13.6M	21.5M	15.8M	49.3M	56.7M	59.6M
Total Current Assets	28.9M	89.7M	96.8M	69.9M	80.3M	66.3M
Accumulated Other Comprehensive Income	(212K)	(171.2M)	(504K)	(406K)	(365.4K)	(383.7K)
Capital Stock	(233.3M)	113K	114K	127K	146.1K	153.4K
Net Working Capital	18.3M	81.6M	79.4M	49.5M	57.0M	52.1M
Common Stock	(233.3M)	113K	114K	127K	146.1K	153.4K

When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock:

How To Invest In Enfusion

Details

Is Enfusion Stock a good investment?

Details

What is Enfusion's Net Worth?

Details

Largest Application Software Companies

View

Largest Software - Application Companies

View

To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.

You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.27)

Earnings Share

0.04

Revenue Per Share

2.155

Quarterly Revenue Growth

0.154

Return On Assets

0.0592

The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Enfusion Historical Balance Sheet

Enfusion Inventory

7.37 Million

About Enfusion Balance Sheet Analysis

Enfusion Balance Sheet Chart

Total Assets

Total Current Liabilities

Enfusion balance sheet Correlations

Enfusion Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Enfusion balance sheet Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Non Currrent Assets Other	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Non Currrent Assets Other	+ 1.0	Non Current Assets Total
Total Liab	+ 1.0	Non Current Liabilities Total

Net Invested Capital	- 0.99	Current Deferred Revenue
Other Stockholder Equity	- 0.99	Current Deferred Revenue
Non Current Liabilities Total	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.99	Total Stockholder Equity
Total Liab	- 0.98	Net Tangible Assets
Total Liab	- 0.98	Total Stockholder Equity